Meeting
2019 Gastrointestinal Cancers Symposium
KRAS mutation is associated with upregulation of integrin beta-4 expression leading to tumor invasion in colorectal cancer.
Authors
Seo-Hyun Choi
Memorial Sloan Kettering Cancer Center, New York, NY
Seo-Hyun Choi , Michael Marco , Ching-Tung Chen , Raphael Pelossof , Kevin Patrick O'Rourke , Jesse Joshua Smith , Julio Garcia-Aguilar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 576)
DOI
10.1200/JCO.2019.37.4_suppl.576
Abstract #
576
Poster Bd #
G19
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Identification of MAPK and mTOR pathway alterations in HER2-amplified colorectal cancer.
First Author: Svea Cheng
Poster
2019 Gastrointestinal Cancers Symposium
A KRAS mutation is associated with an immunosuppressive tumor microenvironment in mismatch-repair proficient colorectal cancer.
First Author: Michael Marco
Poster
2024 ASCO Breakthrough
Quantitative evaluation of oncogenic KRAS signaling and therapeutic effects of molecular-targeted drugs in living cells by single-molecule imaging.
First Author: Ryoma Yokoi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.
First Author: Khalid Jazieh